Articles & Resources

Videos

Below is a collection of articles, resources and stories from the Invetech team and industry experts, sharing their knowledge, experiences and advice on product development and market trends.

Videos

Clear filter

Key Considerations for Automating Cell Therapy Manufacturing Processes

Invetech’s Jon Ellis and TreeFrog Therapeutics’ Maxime Feyeux discuss cell therapy process automation, development time and costs and automating ancillary processes.

The Drive to More Near-Patient Testing Post-COVID

In this episode of Spilling the Tea, we talk with David Satchell of Satch Medical Consulting about how large diagnostics companies and startups alike are addressing the drive towards near-patient testing.

Fundraising and Venture Capital Trends with Caza Health

In this episode of Spilling the Tea, we talk with Peggy Robinson of Caza Health about fundraising during the pandemic, venture capital and grant trends post-COVID, keeping your vision and when to pivot as a startup.

How COVID is Accelerating Multi-Drug Resistant Infections with Selux Dx

In this episode of Spilling the Tea, we talk with Steve Lufkin of Selux Diagnostics about building a company culture during a pandemic, changes in the antibiotic susceptibility testing (AST) market and the current fundraising environment.

The Future of Complex POC Tests with MDC Associates

In the first episode of our new “Spilling the Tea” interview series, we talk with Joen Johansen of MDC Associates about government and private partnerships and the future of complex POC tests.

Commercializing Disruptive Technologies in Advanced Therapies

From the back of the napkin to the bedside: Panelists from CUTISS, Humacyte and TreeFrog Therapeutics share their inspirational journeys commercializing disruptive technologies

Emergency Use Authorization: How IVD Developers Can Use the EUA to Address COVID-19

Watch our interview with Fran White of MDC Associates on using the EUA for COVID-19 testing to fast track approval, what’s required by the FDA and how to plan for an eventual 510(k).

Got Approval… Now What? Meeting Cell Therapy Market Demand

Panelists from bluebird bio, DiscGenics and Proteus, LLC share their vision for commercial manufacturing of cell therapies.

What’s Next for Commercial Cell Therapy Manufacturing?

Now it's getting serious. Panelists from bluebird bio, Juno Therapeutics and Hitachi Chemical Advanced Therapeutics Solutions (HCATS) discuss their vision for the coming era of industrialized cell therapy production.